Research and Markets has announced the addition of the "Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016" report to their offering.
Alpha-Synuclein (alphaSyn or SNCA) Alpha-synuclein is a protein normally found in cells all over the body. It is one of the key players in Parkinson's. In Parkinson's it forms clumps inside the specific nerve cells that produce the chemical dopamine. It is involved in the regulation of dopamine release and transport. It induces fibrillization of microtubule-associated protein tau. It reduces neuronal responsiveness to various apoptotic stimuli, leading to decreased caspase-3 activation.
Alpha-Synuclein (alphaSyn or SNCA) pipeline Target constitutes close to 29 molecules, out of which approximately 24 molecules are developed by Companies and the remaining by the Universities/Institutes. The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 5, 13 and 5 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules.
The report "Alpha-Synuclein - Pipeline Review, H1 2016" outlays comprehensive information on the Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/2ccs92/alphasynuclein
Related Topics: Central Nervous System Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831005735/en/Business Wire
Last updated on: 31/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.